Non-invasive therapy for keratoconus – Ultrasound enhanced delivery of riboflavin to cornea for transepithelial corneal collagen crosslinking [ 2015 - 2018 ]

Research Grant

Researchers: Dr Hong Zhang (Principal investigator) ,  A/Pr Mark Daniell ,  Dr Elsie Chan ,  Dr Harry Unger ,  Dr Katharina Ladewig
View all 7 related researchers

Brief description Keratoconus is a degenerative eye disease which causes corneal thinning. The disease causes visual distortions & loss of vision, and is commonly treated with Corneal Cross-Linking. This involves scraping off the outer protective layer of the cornea so that treatment can be applied. This is painful for patients and carries many risks. This grant assists in the development of a device that is able to deliver the reagent in a painless, non-invasive, effective and safe way.

Funding Amount $AUD 600,658.20

Funding Scheme Development Grants

Notes Development Grant